This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Stewart D Jolly: Innovator in Pharmaceutical Chemistry
Introduction
Stewart D Jolly is a notable inventor based in Bristol, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of various compounds.
Latest Patents
Stewart D Jolly holds a patent for "Crystalline forms - 11-piperazin-1-yldibenzo[b,f][1,4]thiazepine, compositions thereof, preparations thereof, formulations thereof, prodrugs thereof and pharmaceutical uses thereof." This patent highlights his expertise in developing new pharmaceutical formulations that can enhance therapeutic efficacy.
Career Highlights
Stewart is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on advancing drug development and improving patient outcomes through innovative pharmaceutical solutions.
Collaborations
Throughout his career, Stewart has collaborated with esteemed colleagues, including Karen Beth Main and Alan S Kirschner. These collaborations have fostered a productive environment for research and development in the pharmaceutical sector.
Conclusion
Stewart D Jolly's contributions to pharmaceutical chemistry and his innovative patent work exemplify his commitment to advancing medical science. His collaborations and career at AstraZeneca further underscore his impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile